InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-38.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by MacBeath Gavin, Directeur Scientifique. Director active across 1 company, notably TScan Therapeutics, Inc.. In total, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €26k. History available since 20 September 2021. The latest transaction was disclosed on 20 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to MacBeath Gavin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
4,943 股@ US$6.2197100.0% 占其流量Voting Common StockSEC:0000899243-21-037147:0
标准退出：2021年12月19日 (T+90)
1 条申报中的 1 条
About MacBeath Gavin
Gavin MacBeath is the Chief Scientific Officer of TScan Therapeutics, Inc. In this role, he is responsible for leading the company's research and development initiatives. With a strong scientific background, he plays a key role in innovation and the development of new therapies. His expertise is essential in ensuring that TScan's products meet the highest standards of safety and efficacy.
